Ken Griffin Biotechnology

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024

Stock List

Stock Option Type Value Options Held Last Trade Trade History
BBIO
Bridge Bio Pharma, Inc.
PUT
$5.84 Million
229K
Q3 2024
Added 36.43%
PCVX
Vaxcyte, Inc.
PUT
$5.33 Million
46.7K
Q3 2024
New holding
RVMD
Revolution Medicines, Inc.
PUT
$5.23 Million
115K
Q3 2024
Reduced 31.28%
APLS
Apellis Pharmaceuticals, Inc.
PUT
$5.22 Million
181K
Q3 2024
Added 28.75%
UTHR
United Therapeutics Corp
PUT
$5.12 Million
14.3K
Q1 2024
Added 823.41%
ADMA
Adma Biologics, Inc.
CALL
$4.2 Million
210K
Q2 2024
Reduced 89.7%
APLS
Apellis Pharmaceuticals, Inc.
CALL
$4.15 Million
144K
Q3 2024
Added 28.75%
ASND
Ascendis Pharma A/S
PUT
$3.99 Million
26.7K
Q3 2024
Added 23.46%
RXRX
Recursion Pharmaceuticals, Inc.
PUT
$3.67 Million
557K
Q3 2024
Reduced 68.56%
ROIV
Roivant Sciences Ltd.
PUT
$3.43 Million
297K
Q3 2024
Added 208.11%
JAZZ
Jazz Pharmaceuticals PLC
CALL
$3.41 Million
30.6K
Q3 2024
Added 171.04%
ARDX
Ardelyx, Inc.
PUT
$3.35 Million
487K
Q3 2024
Added 747.53%
ACLX
Arcellx, Inc.
PUT
$3.22 Million
38.6K
Q3 2024
New holding
IOVA
Iovance Biotherapeutics, Inc.
CALL
$3.08 Million
328K
Q3 2024
Added 320.88%
AUPH
Aurinia Pharmaceuticals Inc.
PUT
$3.04 Million
415K
Q3 2024
Reduced 41.69%
EXEL
Exelixis, Inc.
PUT
$3.04 Million
117K
Q3 2024
Added 1332.67%
ASND
Ascendis Pharma A/S
CALL
$2.96 Million
19.8K
Q3 2024
Added 23.46%
CLDX
Celldex Therapeutics, Inc.
CALL
$2.85 Million
83.9K
Q3 2024
Added 163.78%
TECH
Bio Techne Corp
CALL
$2.8 Million
35.1K
Q3 2024
Added 366.96%
CORT
Corcept Therapeutics Inc
PUT
$2.8 Million
60.6K
Q3 2024
Reduced 51.96%
IMVT
Immunovant, Inc.
PUT
$2.72 Million
98.7K
Q3 2024
Reduced 1.05%
ACLX
Arcellx, Inc.
CALL
$2.61 Million
31.2K
Q3 2024
New holding
NTLA
Intellia Therapeutics, Inc.
PUT
$2.53 Million
123K
Q3 2024
Added 29.73%
HALO
Halozyme Therapeutics, Inc.
PUT
$2.5 Million
43.7K
Q2 2024
Added 15.37%
RYTM
Rhythm Pharmaceuticals, Inc.
CALL
$2.46 Million
47K
Q3 2024
New holding
RPRX
Royalty Pharma PLC
CALL
$2.44 Million
86.1K
Q1 2024
Reduced 79.89%
BMEA
Biomea Fusion, Inc.
CALL
$2.38 Million
235K
Q3 2024
Reduced 99.77%
IMVT
Immunovant, Inc.
CALL
$2.36 Million
85.7K
Q3 2024
Reduced 1.05%
ARDX
Ardelyx, Inc.
CALL
$2.35 Million
341K
Q3 2024
Added 747.53%
JANX
Janux Therapeutics, Inc.
PUT
$2.32 Million
51.1K
Q3 2024
Reduced 35.15%
CAPR
Capricor Therapeutics, Inc.
CALL
$2.31 Million
152K
Q2 2024
Added 117.23%
IONS
Ionis Pharmaceuticals Inc
CALL
$2.28 Million
56.9K
Q3 2024
Reduced 36.02%
BEAM
Beam Therapeutics Inc.
CALL
$2.28 Million
92.9K
Q3 2024
Added 94.52%
HALO
Halozyme Therapeutics, Inc.
CALL
$2.27 Million
39.6K
Q2 2024
Added 15.37%
TVTX
Travere Therapeutics, Inc.
PUT
$2.19 Million
157K
Q3 2024
Added 21.05%
LQDA
Liquidia Corp
CALL
$2.17 Million
217K
Q3 2024
New holding
ANVS
Annovis Bio, Inc.
PUT
$2.13 Million
265K
Q3 2024
New holding
RXRX
Recursion Pharmaceuticals, Inc.
CALL
$1.97 Million
299K
Q3 2024
Reduced 68.56%
IMTX
Immatics N.V.
PUT
$1.96 Million
172K
Q3 2024
Added 116.94%
RARE
Ultragenyx Pharmaceutical Inc.
CALL
$1.93 Million
34.8K
Q3 2024
Reduced 72.43%
TERN
Terns Pharmaceuticals, Inc.
PUT
$1.92 Million
231K
Q3 2024
Added 151.6%
RNA
Avidity Biosciences, Inc.
CALL
$1.9 Million
41.4K
Q2 2024
Added 55.89%
ALT
Altimmune, Inc.
CALL
$1.88 Million
306K
Q3 2024
Added 41779.24%
IBRX
Immunity Bio, Inc.
PUT
$1.87 Million
505K
Q3 2024
Added 45.69%
EWTX
Edgewise Therapeutics, Inc.
CALL
$1.87 Million
70K
Q3 2024
Reduced 77.09%
ZLAB
Zai Lab LTD
PUT
$1.75 Million
72.3K
Q3 2024
Added 48.54%
MIRM
Mirum Pharmaceuticals, Inc.
CALL
$1.72 Million
44.1K
Q3 2024
Reduced 12.25%
EWTX
Edgewise Therapeutics, Inc.
PUT
$1.68 Million
62.8K
Q3 2024
Reduced 77.09%
HUMA
Humacyte, Inc.
PUT
$1.66 Million
305K
Q3 2024
Added 248.83%
Filter Shares Options
Ken Griffin

Ken Griffin

Ken Griffin is the founder and CEO of Citadel Advisors, a successful investment firm that uses technology and data-driven approaches to investing. Griffin is known for his expertise in quantitative investing and his innovative approach to investing. He has generated strong returns for his clients over the long term.
Track Ken Griffin's portfolio
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email